Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 585 | 2017 |
Glial response during cuprizone-induced de-and remyelination in the CNS: lessons learned V Gudi, S Gingele, T Skripuletz, M Stangel Frontiers in cellular neuroscience 8, 73, 2014 | 397 | 2014 |
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination T Skripuletz, D Hackstette, K Bauer, V Gudi, R Pul, E Voss, K Berger, ... Brain 136 (1), 147-167, 2013 | 384 | 2013 |
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent T Skripuletz, M Lindner, A Kotsiari, N Garde, J Fokuhl, F Linsmeier, ... The American journal of pathology 172 (4), 1053-1061, 2008 | 305 | 2008 |
Regional differences between grey and white matter in cuprizone induced demyelination V Gudi, D Moharregh-Khiabani, T Skripuletz, PN Koutsoudaki, A Kotsiari, ... Brain research 1283, 127-138, 2009 | 266 | 2009 |
De-and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected T Skripuletz, V Gudi, D Hackstette, M Stangel Histology and histopathology, Vol. 26, nº12 (2011), 2011 | 241 | 2011 |
Characterisation of microglia during de-and remyelination: can they create a repair promoting environment? EV Voß, J Škuljec, V Gudi, T Skripuletz, R Pul, C Trebst, M Stangel Neurobiology of disease 45 (1), 519-528, 2012 | 214 | 2012 |
Cuprizone [bis (cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes K Bénardais, A Kotsiari, J Škuljec, PN Koutsoudaki, V Gudi, V Singh, ... Neurotoxicity research 24, 244-250, 2013 | 148 | 2013 |
Demyelination of the hippocampus is prominent in the cuprizone model PN Koutsoudaki, T Skripuletz, V Gudi, D Moharregh-Khiabani, ... Neuroscience letters 451 (1), 83-88, 2009 | 132 | 2009 |
CXCL10 triggers early microglial activation in the cuprizone model T Clarner, K Janssen, L Nellessen, M Stangel, T Skripuletz, B Krauspe, ... The Journal of Immunology 194 (7), 3400-3413, 2015 | 130 | 2015 |
Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo U Forssmann, C Stoetzer, M Stephan, C Kruschinski, T Skripuletz, ... The Journal of Immunology 181 (2), 1120-1127, 2008 | 130 | 2008 |
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients S Gingele, TL Jacobus, FF Konen, MW Hümmert, KW Sühs, ... Cells 8 (1), 12, 2018 | 124 | 2018 |
Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab therapy—review of the literature and future outlook N Möhn, G Beutel, R Gutzmer, P Ivanyi, I Satzger, T Skripuletz Journal of Clinical Medicine 8 (11), 1777, 2019 | 122 | 2019 |
Cerebellar cortical demyelination in the murine cuprizone model T Skripuletz, JH Bussmann, V Gudi, PN Koutsoudaki, R Pul, ... Brain pathology 20 (2), 301-312, 2010 | 122 | 2010 |
Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization P Schwenkenbecher, R Pul, U Wurster, J Conzen, K Pars, H Hartmann, ... BMC infectious diseases 17, 1-10, 2017 | 114 | 2017 |
Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming V Gudi, J Škuljec, Ö Yildiz, K Frichert, T Skripuletz, D Moharregh-Khiabani, ... PloS one 6 (7), e22623, 2011 | 107 | 2011 |
Pivotal role of choline metabolites in remyelination T Skripuletz, A Manzel, K Gropengießer, N Schäfer, V Gudi, V Singh, ... Brain 138 (2), 398-413, 2015 | 103 | 2015 |
Impact of the McDonald criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis P Schwenkenbecher, U Wurster, FF Konen, S Gingele, KW Sühs, ... Frontiers in neurology 10, 188, 2019 | 99 | 2019 |
CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model C Kruschinski, T Skripuletz, S Bedoui, T Tschernig, R Pabst, ... Clinical & Experimental Immunology 139 (1), 17-24, 2005 | 82 | 2005 |
Neuro-Sjögren: peripheral neuropathy with limb weakness in Sjögren's syndrome T Seeliger, NK Prenzler, S Gingele, B Seeliger, S Körner, T Thiele, ... Frontiers in Immunology 10, 446252, 2019 | 81 | 2019 |